Form D · Pharmaceuticals
REGENERX BIOPHARMACEUTICALS INC
Rockville, MD · CIK 0000707511
Offering snapshot reported Mar 7, 2019 · SEC filing
- Reported sold
- $1.3M Offering amount: $1.3M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Feb 27, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 7, 2019 | Initial | $1,300,000 | No comparison | 2 | SEC filing |
| Mar 19, 2018 | Initial | $888,253 | No comparison | 2 | SEC filing |
| Jul 13, 2016 | Initial | $4,375,000 | No comparison | 2 | SEC filing |
| Jan 19, 2011 | Initial | $258,750 | No comparison | 1 | SEC filing |
| Jan 19, 2011 | Initial | Yet to sell | No comparison | 1 | SEC filing |
| Jan 19, 2011 | Initial | $950,000 | No comparison | 3 | SEC filing |
| Oct 26, 2009 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| May 13, 2009 | Initial | $600,000 | No comparison | Not reported | SEC filing |
| Dec 31, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 13, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 14, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Debt, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-334305
covertible notes and warrants
Source: Form D, filed Mar 7, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mauro Bove | Director |
| L. Thompson Bowles | Director |
| David Crockford | Executive |
| R. Don Elsey | Director |
| R. Don Elsey | Director |
| R Don Elsey | Director |
| J.J. Finkelstein | Executive |
| Allan L Goldstein | Director |
| Richard Hindin | Director |
| C. Neil Lyons | Executive |
| Joseph C. Mcnay | Director |
| Joseph Mc Nay | Director |
| Jospeh Mc Nay | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
15245 Shady Grove Road Suite 470
Rockville, MD, 20850
Rockville, MD, 20850